CD8A and neoplasm: Interestingly however, while not statistically significant, our analysis revealed that high infiltrations of CD3+, CD8+, or FoxP3+ T lymphocytes in the tumor margins resulted in increased overall survival of 13.4 (p = 0.117), 7 (p = 0.224), and 14 months (p = 0.092), respectively.